Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05817721Completed

PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents

Role: collaborator

NCT06328101Not Yet Recruiting

Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR)

Role: collaborator

NCT03158298Terminated

Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas

Role: collaborator

NCT02820675Not ApplicableCompleted

Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions

Role: collaborator

All 4 trials loaded